Carlit (4275) FY2027 Q1 Earnings Report

Quick View

Executive Summary

In FY2027 Q1, Revenue remained broadly in line with the same period of the previous year, while both Operating Income and Net Income declined significantly, making the deterioration in profitability the primary focus. Revenue was ¥8.65B (YoY +0.0%), while Operating Income was ¥0.25B (down 42.7%), Ordinary Income was ¥0.39B (down 33.7%), and Net Income was ¥0.07B (down 77.3%). The main causes of the decline in Operating Income were the lower profit margin in the core Chemicals Business and the widening losses in the Bottling Business, while Net Income was further compressed by the high tax burden associated with an effective tax rate of 84.6%.

Factors Affecting Results

【Revenue】Revenue was ¥8.65B, essentially flat year on year (+0.0%). While Engineering Services (+14.4% based on the aggregated figure, although -13.7% is stated in the disclosure), Metal Processing (+1.8%), and Chemicals (+1.9%) recorded higher revenue, Bottling declined significantly by -28.7%, offsetting growth across the Company. Chemicals accounts for slightly more than 60% of total Company revenue, creating a structure in which the performance of this business determines the Company’s overall top-line results.

【Profit and Loss】Operating Income was ¥0.25B (down 42.7% year on year), and the Operating Margin declined to 2.9%. The primary causes were a 53.1% decline in segment profit in Chemicals and an expansion of Bottling’s loss to ¥0.37B; these could not be fully offset by higher profit in Metal Processing and Engineering Services. Supported mainly by ¥0.14B in dividend income included in ¥0.16B of non-operating income, Ordinary Income was ¥0.39B (down 33.7%), while Net Income was compressed to ¥0.07B (down 77.3%) by the high burden of ¥0.38B in income taxes and other taxes (effective tax rate: 84.6%). In conclusion, this was a profit decline without revenue growth—in other words, an earnings decline driven by profitability.

Segment Analysis

Segment profit in Chemicals deteriorated rapidly to ¥0.20B (down 53.1% year on year; margin 3.9% versus 8.4% in the previous year). Bottling generated revenue of ¥0.66B (down 28.7%) and an Operating Loss of ¥0.37B, widening from a loss of ¥0.30B in the previous year, making it the largest drag on profitability. Meanwhile, Metal Processing recorded revenue of ¥1.90B (+1.8%) and profit of ¥0.18B (+2.3%; margin 9.3%), while Engineering Services generated revenue of ¥1.04B and profit of ¥0.20B (+29.7%; margin 19.8%), maintaining the highest profitability among the four businesses. The profitability gap between businesses is widening, and the recovery of profitability in Chemicals and Bottling will be key to improving Company-wide results.

Key Financial Indicators

【Profitability】The Operating Margin of 2.9%, Ordinary Income Margin of 4.5%, and Net Profit Margin of 0.8% all declined significantly from the same period of the previous year, when the Operating Margin was approximately 5.1%. ROE remained low at 0.2% (based on Net Income). 【Cash Flow Quality】The divergence between Ordinary Income and Net Income was primarily attributable to income taxes and other taxes of ¥0.38B against pre-tax income of ¥0.45B, resulting in an effective tax rate of 84.6% and substantially compressing Q1 earnings. 【Investment Efficiency】Net Income was minimal relative to total assets of ¥57.53B, indicating room for improvement in both asset turnover and profitability. 【Financial Soundness】With an Equity Ratio of 65.9% (versus 69.0% in the previous year), cash and deposits of ¥3.99B, and long-term borrowings of ¥3.09B, the debt level remains low and the financial foundation continues to be solid.

Cash Flow Analysis

As this report does not include direct data from the cash flow statement, funding trends are reviewed based on changes in the balance sheet. Cash and deposits were ¥3.99B, remaining almost flat compared with ¥3.99B in the same period of the previous year. Accounts receivable and notes receivable were ¥8.88B, down from ¥9.50B in the same period of the previous year, while inventories were ¥3.41B, broadly flat compared with ¥3.45B in the same period of the previous year. Short-term borrowings declined significantly to ¥1.20B from ¥3.50B in the same period of the previous year, while long-term borrowings increased to ¥3.09B from ¥0.35B, suggesting that the borrowing structure shifted from short term to long term. Net assets declined to ¥37.91B from ¥39.79B in the previous year, with the stagnation in retained earnings growth and fluctuations in shareholders’ equity having a slight impact on the funding base.

Earnings Quality

Ordinary Income of ¥0.39B exceeded Operating Income of ¥0.25B by ¥0.13B, primarily due to ¥0.16B in non-operating income, centered on ¥0.14B in dividend income. Dividend income was equivalent to 52.9% of Operating Income and, although recurring in nature, does not substitute for deteriorating profitability in the core business. In extraordinary gains and losses, a ¥0.07B gain on the sale of shares in a subsidiary was recorded, and after deducting a ¥0.01B loss on the disposal of fixed assets, the resulting net gain of ¥0.06B temporarily lifted pre-tax income. Against pre-tax income of ¥0.45B, Net Income was only ¥0.07B, with the divergence attributable to the high tax burden of ¥0.38B in income taxes and other taxes (effective tax rate: 84.6%). Accordingly, evaluating recurring earning power solely on the basis of Q1 Net Income may result in an undervaluation.

Earnings Forecasts and Guidance

The full-year Company plan calls for Revenue of ¥37.20B (up 2.6% year on year), Operating Income of ¥3.20B (down 7.5%), and Ordinary Income of ¥3.30B (down 12.1%), indicating that the Company’s plan itself assumes a more cautious profit level than in the previous year. While the Q1 progress rate for Revenue was 23.3%, close to the standard 25%, progress rates for Operating Income and Ordinary Income were only 8.0% and 11.7%, respectively, substantially below the standard level. The decline in Chemicals’ profit margin and the widening Bottling losses were the primary causes of the delayed progress. As neither the earnings forecast nor the dividend forecast has been revised, a recovery in profitability in the second half of the fiscal year is a prerequisite for achieving the plan.

Shareholder Returns

The full-year dividend forecast is ¥42.00 per share, and the forecast Payout Ratio based on full-year forecast EPS of ¥133.61 is 31.4%, below the generally cited sustainability benchmark of 60%. Although Q1 Net Income was low at ¥0.07B, this was largely due to temporary compression caused by the higher effective tax rate; assessment of the full-year dividend will depend on the degree to which the full-year Net Income plan of ¥3.00B is achieved. Retained earnings were substantial at ¥30.26B, supporting continued dividend payments from the standpoint of capital accumulation. No revision has been made to the dividend forecast.

Risk Factors

1. Deterioration in Chemicals Business profitability: Despite Revenue of ¥5.16B (up 2.3% year on year), segment profit declined to ¥0.20B (down 53.1%), and the profit margin fell from 8.4% to 3.9%. Lower profitability in the core business, which accounts for 60% of Revenue, would have a significant impact on Company-wide profit.

2. Widening losses in the Bottling Business: Against Revenue of ¥0.66B (down 28.7% year on year), the Operating Loss widened to ¥0.37B (versus a loss of ¥0.30B in the previous year). If insufficient fixed-cost absorption in response to declining demand continues, it could become a downside factor for Company-wide profit.

3. Compression of Net Income due to the high effective tax rate: Income taxes and other taxes of ¥0.38B were incurred against pre-tax income of ¥0.45B, resulting in an effective tax rate of 84.6%. If this level continues, it could cause downside risk to full-year Net Income and EPS.

Industry Benchmark (For Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Margin and Net Profit Margin are substantially below the industry median, placing profitability toward the lower end of the industry.

※Source: Company analysis

Key Points from the Earnings Results

1. As Revenue remained broadly in line with the same period of the previous year while Operating Income declined 42.7%, the focus of the Q1 results is not revenue growth but profitability recovery. The profit margin in the core Chemicals Business declined by approximately 4.5 percentage points year on year, making trends in the business’s profitability a key area of attention going forward.

2. The Bottling Business Operating Loss widened to ¥0.37B, with the loss increasing from the same period of the previous year. The degree of improvement in fixed-cost absorption will be a key monitoring point going forward.

3. Against the full-year Operating Income plan of ¥3.20B, the Q1 progress rate was only 8.0%, substantially below the standard progress rate of 25%. Financial soundness remains strong, with an Equity Ratio of 65.9%, indicating relatively high financial resilience until earnings recover.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,605–¥1,698 at ±1% for the cost of equity, and ¥1,648–¥1,652 at ±0.1 for ω.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing gap relative to the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 performance was weak: flat revenue was accompanied by a sharp decline in operating and net profit. Revenue was ¥8.654bn, unchanged year on year, while operating income fell 42.7% to ¥0.255bn. Gross profit increased 3.8% to ¥1.983bn despite unchanged sales. The gross margin improved 80bp year on year to 22.9%, from 22.1%. However, SG&A expenses rose 17.9% to ¥1.728bn. Consequently, the SG&A-to-sales ratio increased by approximately 310bp to 20.0%. The operating margin therefore compressed by approximately 220bp to 2.9%, below the 5% profitability concern threshold. Ordinary income declined 33.7% to ¥0.385bn. Dividend income of ¥0.135bn accounted for 35.1% of ordinary income and was the principal component of ¥0.161bn in non-operating income. Profit before tax was ¥0.448bn, supported by a ¥0.074bn gain on sales of subsidiary shares. Net income fell 77.0% to ¥0.068bn because income tax expense reached ¥0.379bn, equivalent to an 84.6% effective tax rate. The annualized ROE was only 0.7%, reflecting a 0.8% net margin rather than excessive leverage. Segment performance was mixed, with Engineering Services producing the largest segment profit at ¥0.205bn, while Chemicals experienced the largest absolute profit decline. The Bottling segment remained structurally loss-making and its revenue contraction intensified the consolidated margin pressure. The full-year plan implies a significant recovery after Q1, particularly at the operating-profit level. Delivery against this recovery depends on restoring Chemicals profitability, limiting Bottling losses, and converting revenue growth in Engineering Services into sustained earnings.

Profitability Analysis

The annualized three-factor DuPont ROE is 0.7%, comprising a 0.8% net profit margin, 0.602x asset turnover, and 1.52x financial leverage. The principal constraint is the net margin, which is substantially below the 3% concern threshold and declined sharply with net income. Financial leverage is moderate and is not the source of the weak return profile. Asset turnover of 0.602x on an annualized basis is modest for a manufacturing group with substantial fixed assets and investment securities. The operating margin declined to 2.9% from approximately 5.1% in the prior-year quarter, despite an 80bp improvement in gross margin. This divergence shows that operating deleverage was driven predominantly by SG&A growth rather than deterioration in gross profitability. SG&A increased by ¥0.262bn year on year, exceeding the ¥0.072bn increase in gross profit and more than offsetting it. Chemicals, the largest segment by external revenue at ¥5.159bn, saw segment profit decline 53.1% to ¥0.203bn; its segment margin on total segment sales fell to 3.8% from 8.2%. Engineering Services was the core business by segment-profit contribution, generating ¥0.205bn of profit on ¥1.036bn of total segment sales, for a 19.8% margin. Metal Processing remained profitable, with segment profit up 2.3% to ¥0.176bn and a 9.3% margin on total segment sales. Bottling reported a ¥0.367bn segment loss, worsening from a ¥0.301bn loss. The five-factor profile also shows a tax burden of 0.152, while the interest burden exceeded 1.0 because non-operating income, notably dividends, more than offset interest costs. Interest coverage was a still-adequate 8.79x, but low operating efficiency and a 1.3% ROIC indicate that the asset base is currently generating insufficient operating returns.

Growth Assessment

Consolidated revenue was flat at ¥8.654bn, indicating that the Q1 earnings decline was not caused by a broad-based sales contraction. Segment revenue trends were divergent. Chemicals external sales grew 2.3% to ¥5.159bn, but this did not translate into profit growth. Metal Processing external sales increased 1.7% to ¥1.863bn and segment profit remained stable to slightly higher. Engineering Services external sales increased 14.4% to ¥0.967bn, with segment profit rising 29.7% to ¥0.205bn. Bottling external sales declined 28.7% to ¥0.664bn, compounding its operating loss. The full-year forecast calls for revenue of ¥37.2bn, up 2.6% year on year, operating income of ¥3.2bn, ordinary income of ¥3.3bn, and net income attributable to owners of ¥3.0bn. Q1 revenue represents 23.3% of the full-year revenue forecast, only 1.7 percentage points below the standard 25% Q1 seasonal benchmark. Q1 operating income represents just 8.0% of the full-year operating-income forecast, 17.0 percentage points below the standard benchmark. Ordinary-income progress is 11.7%, and net-income progress is 2.3%, both also substantially below a normal Q1 run rate. The forecast therefore requires a material improvement in profitability from Q2 onward, rather than merely seasonal revenue growth. As the full-year operating-income forecast is itself 7.5% below the prior full-year result, the planned recovery should be assessed against a lower full-year profit base rather than interpreted as an aggressive expansion target.

Financial Health

Liquidity remains sound. The current ratio is 194.4% and the quick ratio is 162.7%, both comfortably above prudent thresholds. Working capital was ¥10.170bn, and cash and deposits of ¥3.985bn covered short-term loans of ¥1.200bn by 3.32x. Current assets of ¥20.942bn exceeded current liabilities of ¥10.772bn, reducing near-term refinancing risk. Interest-bearing debt totaled ¥4.288bn, equivalent to approximately 11.3% of total equity, while reported debt-to-equity was 0.52x and debt-to-capital was 10.2%. Solvency is therefore conservative despite the increase in borrowing. Long-term loans increased by ¥2.740bn year on year to ¥3.088bn, while short-term loans declined by ¥2.300bn to ¥1.200bn. This shift lengthens the debt maturity profile and appears consistent with refinancing toward longer-tenor funding. However, the larger long-term debt balance warrants monitoring because Q1 operating income weakened materially and interest expense increased from ¥0.008bn to ¥0.029bn. The 8.79x interest-coverage ratio remains strong and does not indicate immediate debt-service stress. Equity declined ¥1.885bn year on year to ¥37.908bn. Retained earnings declined ¥0.891bn to ¥30.257bn, while treasury stock expanded by ¥0.999bn to a negative ¥1.524bn. The equity reduction and greater treasury-stock balance reduce capital-buffer growth, although the 65.9% capital adequacy ratio remains robust. Investment securities represented 19.2% of total assets, creating meaningful exposure of book value and non-operating income to portfolio valuation and dividend trends.

Notable B/S Changes

Long-term loans: +¥2.740bn (+787.4%) to ¥3.088bn — a significant move toward longer-term funding; it improves the maturity profile relative to short-term borrowing but raises the importance of maintaining operating-profit recovery. Short-term loans: -¥2.300bn (-65.7%) to ¥1.200bn — consistent with reduced short-dated refinancing exposure and supported by cash of ¥3.985bn. Treasury stock: -¥0.999bn (-190.3%) to -¥1.524bn — the larger treasury-stock balance contributed to lower equity and reduces the outstanding-share base. Construction in progress: +¥0.708bn (+28.9%) to ¥3.165bn — the expanding investment pipeline represents 13.8% of PPE and indicates ongoing facility or capacity investment execution requirements. Total equity: -¥1.885bn (-4.7%) to ¥37.908bn — the decline reflects lower retained earnings and the increased treasury-stock balance, although capital adequacy remained high at 65.9%.

Cash Flow Quality

Dividend Sustainability

The full-year dividend forecast is ¥42.00 per share and is unchanged. Against forecast EPS of ¥133.61, the implied dividend payout ratio is 31.4%. This payout level is moderate and leaves a substantial earnings retention buffer under the company forecast. The Q1 EPS of ¥3.10 is not representative of the annual forecast run rate, given the pronounced Q1 shortfall in operating and net-profit progress. Dividend sustainability is therefore more dependent on delivery of the planned second-half earnings recovery than on Q1 reported earnings alone. The unchanged dividend forecast signals management confidence in the full-year plan, but the large gap between Q1 profit progress and the annual target increases execution sensitivity.

Risk Assessment

Business risks include Chemical profitability risk: Chemicals generated ¥5.159bn of external sales but segment profit fell 53.1% to ¥0.203bn, indicating that modest revenue growth is not currently translating into adequate margins., Bottling restructuring risk: external revenue fell 28.7% to ¥0.664bn and the segment loss widened to ¥0.367bn, making it the most immediate drag on group profitability., Manufacturing working-capital risk: annualized receivable days were 94 days, above the 60-day warning threshold. Slow collections can increase funding needs and expose earnings to customer-credit or shipment-timing volatility., Investment-income dependence: dividend income was ¥0.135bn, equal to 35.1% of ordinary income. Changes in investee dividend policies or portfolio returns could materially affect ordinary earnings., Chemical-industry risk: input-cost, energy-cost, environmental-regulatory, and product-safety pressures can affect margins, particularly when operating margins are already below 5%..

Financial risks include High tax burden: the 84.6% effective tax rate reduced ¥0.448bn of profit before tax to only ¥0.068bn of net income. This tax burden is materially above normal corporate tax levels and amplifies volatility in shareholder earnings., Low operating efficiency: the 2.9% EBIT margin and 1.3% ROIC are below 5% benchmarks, leaving limited resilience against cost inflation or further revenue weakness., Borrowing-profile change: long-term loans rose 787.4% year on year to ¥3.088bn. While the maturity shift improves short-term liquidity, sustained weak operating income would reduce the headroom supporting this debt., Capital-market exposure: investment securities of ¥11.052bn and valuation/translation adjustments of ¥7.075bn are material components of the balance sheet and can affect equity through market-price movements..

Key concerns include The full-year operating-income target requires a substantial acceleration because Q1 progress was only 8.0%, versus a standard 25% Q1 progress rate., SG&A expenses increased 17.9% while revenue was flat, causing operating-margin compression despite higher gross profit., The ¥0.074bn gain on sales of subsidiary shares supported pre-tax profit, while the underlying operating result weakened., Receivable days of 94 days are elevated for a manufacturing business and should be monitored alongside receivable balances and collection trends., The tax burden, loss-making Bottling operations, and weak Chemicals segment profit jointly create a high sensitivity of net income to relatively small changes in operating performance..

Investment Implications

Key takeaways include Revenue stability and an 80bp improvement in gross margin were insufficient to offset a ¥0.262bn increase in SG&A expenses., Engineering Services is the core business by Q1 segment-profit contribution, with a 19.8% segment margin on total segment sales and 29.7% profit growth., Chemicals remains the largest revenue contributor but suffered a ¥0.230bn segment-profit decline, making its margin recovery central to group earnings normalization., The balance sheet retains strong liquidity and conservative debt-to-capital of 10.2%, despite a shift from short-term to long-term borrowing., The forecast embeds significant back-end-loaded earnings recovery, with operating-income progress 17 percentage points below the standard Q1 benchmark..

Metrics to watch include Chemicals segment profit and margin recovery, Bottling revenue trend and reduction of the segment loss, SG&A expense growth relative to revenue growth, Operating-margin recovery from 2.9%, Receivable days and accounts receivable balance, Effective tax rate and reconciliation from profit before tax to net income, Operating-income progress relative to the ¥3.2bn full-year forecast, Long-term debt, interest expense, and interest coverage.

Regarding relative positioning, The company combines a strong liquidity position, low debt-to-capital, and a meaningful investment-security portfolio with currently weak operating returns. Its 2.9% operating margin, 0.7% annualized ROE, and 1.3% ROIC place profitability below typical quality thresholds for established manufacturing businesses, while Engineering Services provides a higher-margin counterweight to weak Chemicals profitability and persistent Bottling losses.